Indication
Blastic plasmacytoid dendritic cell neoplasm
Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive hematologic malignancy that arises from clonal precursors of plasmacytoid dendritic cells. Read more about Blastic plasmacytoid dendritic cell neoplasm
2 drugs 2 manufacturers
Drugs that treat it
Common Blastic plasmacytoid dendritic cell neoplasm therapies.
DECNUPAZ (pivekimab sunirine-pvzy)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonBlastic plasmacytoid dendritic cell neoplasm is a rare, aggressive hematologic malignancy that arises from clonal precursors of plasmacytoid dendritic cells.
The disease most commonly presents in older adults, showing a marked male predominance, although it can manifest across any age group.
It primarily affects the skin, bone marrow, peripheral blood, and lymph nodes, frequently presenting as violaceous or purpuric cutaneous nodules, plaques, or ulcerated tumors alongside cytopenias and hepatosplenomegaly.
Pathophysiologically, the malignant cells exhibit a distinct blastic morphology and characteristic immunophenotypic expression, typically co-expressing CD4, CD56, and CD123.
- nih.gov
Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive hematologic malignancy that arises from clonal precursors of plasmacytoid dendritic cells It primarily affects the skin, bone marrow, peripheral blood, and lymph nodes, frequently presenting as violaceous or purpuric cutaneous nodules, plaques, or ulcerated tumors alongside cytopenias and hepatosplenomegaly
- nih.gov
Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive hematologic malignancy that arises from clonal precursors of plasmacytoid dendritic cells
- nih.gov
The disease most commonly presents in older adults, showing a marked male predominance, although it can manifest across any age group It primarily affects the skin, bone marrow, peripheral blood, and lymph nodes, frequently presenting as violaceous or purpuric cutaneous nodules, plaques, or ulcerated tumors alongside cytopenias and hepatosplenomegaly Pathophysiologically, the malignant cells exhibit a distinct blastic morphology and characteristic immunophenotypic expression, typically co-expres...
- dana-farber.org
The disease most commonly presents in older adults, showing a marked male predominance, although it can manifest across any age group
- mdanderson.org
The disease most commonly presents in older adults, showing a marked male predominance, although it can manifest across any age group
- nih.gov
It primarily affects the skin, bone marrow, peripheral blood, and lymph nodes, frequently presenting as violaceous or purpuric cutaneous nodules, plaques, or ulcerated tumors alongside cytopenias and hepatosplenomegaly Pathophysiologically, the malignant cells exhibit a distinct blastic morphology and characteristic immunophenotypic expression, typically co-expressing CD4, CD56, and CD123
Personalize your experience
Follow Blastic plasmacytoid dendritic cell neoplasm and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.